» Articles » PMID: 34680532

In Vitro Disease Models of the Endocrine Pancreas

Overview
Journal Biomedicines
Date 2021 Oct 23
PMID 34680532
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

The ethical constraints and shortcomings of animal models, combined with the demand to study disease pathogenesis under controlled conditions, are giving rise to a new field at the interface of tissue engineering and pathophysiology, which focuses on the development of in vitro models of disease. In vitro models are defined as synthetic experimental systems that contain living human cells and mimic tissue- and organ-level physiology in vitro by taking advantage of recent advances in tissue engineering and microfabrication. This review provides an overview of in vitro models and focuses specifically on in vitro disease models of the endocrine pancreas and diabetes. First, we briefly review the anatomy, physiology, and pathophysiology of the human pancreas, with an emphasis on islets of Langerhans and beta cell dysfunction. We then discuss different types of in vitro models and fundamental elements that should be considered when developing an in vitro disease model. Finally, we review the current state and breakthroughs in the field of pancreatic in vitro models and conclude with some challenges that need to be addressed in the future development of in vitro models.

Citing Articles

Oxygenation and function of endocrine bioartificial pancreatic tissue constructs under flow for preclinical optimization.

Moeun B, Lemaire F, Smink A, Ebrahimi Orimi H, Leask R, de Vos P J Tissue Eng. 2025; 16:20417314241284826.

PMID: 39866963 PMC: 11758540. DOI: 10.1177/20417314241284826.


Development of a novel NiCu nanoparticle-loaded polysaccharide-based hydrogel for 3D printing of customizable dressings with promising cytotoxicity against melanoma cells.

Curic L, Suligoj M, Ibic M, Marovic N, Vihar B, Vesenjak M Mater Today Bio. 2023; 22:100770.

PMID: 37636985 PMC: 10448318. DOI: 10.1016/j.mtbio.2023.100770.


LncRNA ARGI Contributes to Virus-Induced Pancreatic β Cell Inflammation Through Transcriptional Activation of IFN-Stimulated Genes.

Gonzalez-Moro I, Garcia-Etxebarria K, Mendoza L, Fernandez-Jimenez N, Mentxaka J, Olazagoitia-Garmendia A Adv Sci (Weinh). 2023; 10(25):e2300063.

PMID: 37382191 PMC: 10477904. DOI: 10.1002/advs.202300063.


Overview of Transcriptomic Research on Type 2 Diabetes: Challenges and Perspectives.

Tonyan Z, Nasykhova Y, Danilova M, Barbitoff Y, Changalidi A, Mikhailova A Genes (Basel). 2022; 13(7).

PMID: 35885959 PMC: 9319211. DOI: 10.3390/genes13071176.

References
1.
Horvath P, Aulner N, Bickle M, Davies A, Del Nery E, Ebner D . Screening out irrelevant cell-based models of disease. Nat Rev Drug Discov. 2016; 15(11):751-769. DOI: 10.1038/nrd.2016.175. View

2.
Baker L, Tiriac H, Clevers H, Tuveson D . Modeling pancreatic cancer with organoids. Trends Cancer. 2016; 2(4):176-190. PMC: 4847151. DOI: 10.1016/j.trecan.2016.03.004. View

3.
Hammar E, Irminger J, Rickenbach K, Parnaud G, Ribaux P, Bosco D . Activation of NF-kappaB by extracellular matrix is involved in spreading and glucose-stimulated insulin secretion of pancreatic beta cells. J Biol Chem. 2005; 280(34):30630-7. DOI: 10.1074/jbc.M502493200. View

4.
Kondo Y, Toyoda T, Inagaki N, Osafune K . iPSC technology-based regenerative therapy for diabetes. J Diabetes Investig. 2017; 9(2):234-243. PMC: 5835458. DOI: 10.1111/jdi.12702. View

5.
Chen H, Zhuo Q, Ye Z, Xu X, Ji S . Organoid model: A new hope for pancreatic cancer treatment?. Biochim Biophys Acta Rev Cancer. 2020; 1875(1):188466. DOI: 10.1016/j.bbcan.2020.188466. View